
Broccoli Compound Shows Promise Against Friedreich Ataxia by Boosting Frataxin and Neuroprotection
A natural compound from broccoli significantly boosts frataxin levels and activates neuroprotective pathways in preclinical models of Friedreich ataxia, offering a promising, affordable disease-modifying therapy. Currently, there are no approved disease-modifying therapies for Friedreich ataxia, and patient management is predominantly symptomatic and supportive, encompassing physical therapy, cardiac interventions, and diabetes management.
Gold-Standard Human Evidence
Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.